中国实用医药
中國實用醫藥
중국실용의약
China Practical Medical
2015年
35期
3-5
,共3页
腹膜炎%真菌%腹膜透析
腹膜炎%真菌%腹膜透析
복막염%진균%복막투석
Peritonitis%Fungus%Peritoneal dialysis
目的 对比单中心腹膜透析相关性细菌性与真菌性腹膜炎的临床特点, 以期达到更好地预防及治疗.方法 回顾性分析330例腹膜透析患者中发生相关性腹膜炎患者的临床资料.结果 细菌性腹膜炎组患者退出率20.7%, 死亡率15.7%.晚期拔管的死亡率风险比2.6.真菌性腹膜炎组退出率100.0%, 死亡率30.0%;3例死亡的患者拔管后均未进行规律抗真菌治疗.结论 在细菌性腹膜炎中, 早期拔管可改善患者的预后.腹膜透析相关性真菌性腹膜炎临床预后差, 提示拔管后进行规律抗真菌治疗可改善患者的预后.
目的 對比單中心腹膜透析相關性細菌性與真菌性腹膜炎的臨床特點, 以期達到更好地預防及治療.方法 迴顧性分析330例腹膜透析患者中髮生相關性腹膜炎患者的臨床資料.結果 細菌性腹膜炎組患者退齣率20.7%, 死亡率15.7%.晚期拔管的死亡率風險比2.6.真菌性腹膜炎組退齣率100.0%, 死亡率30.0%;3例死亡的患者拔管後均未進行規律抗真菌治療.結論 在細菌性腹膜炎中, 早期拔管可改善患者的預後.腹膜透析相關性真菌性腹膜炎臨床預後差, 提示拔管後進行規律抗真菌治療可改善患者的預後.
목적 대비단중심복막투석상관성세균성여진균성복막염적림상특점, 이기체도경호지예방급치료.방법 회고성분석330례복막투석환자중발생상관성복막염환자적림상자료.결과 세균성복막염조환자퇴출솔20.7%, 사망솔15.7%.만기발관적사망솔풍험비2.6.진균성복막염조퇴출솔100.0%, 사망솔30.0%;3례사망적환자발관후균미진행규률항진균치료.결론 재세균성복막염중, 조기발관가개선환자적예후.복막투석상관성진균성복막염림상예후차, 제시발관후진행규률항진균치료가개선환자적예후.
Objective To compare clinical characteristics of monocentric peritoneal dialysis-related bacterial and fungal peritonitis, in order to achieve better prevention and treatment.Methods Clinical data of 330 patients with peritoneal dialysis-related peritonitis were retrospectively analyzed.Results The exit rate and mortality rate in bacterial peritonitis group were 20.7% and 15.7%. The death risk of late extubation was 2.6. Fungal peritonitis group had exit rate and mortality rate as 100.0% and 30.0%. There were 3 death cases without regular antifungal therapy after extubation.Conclusion Early extubation can improve prognosis of bacterial peritonitis. Due to poor clinical prognosis of peritoneal dialysis-related fungal peritonitis, implement of regular antifungal therapy after extubation can improve patients' prognosis.